Cite

HARVARD Citation

    Hulsebosch, S. et al. (2022). Ultra‐long‐acting recombinant insulin for the treatment of diabetes mellitus in dogs. Journal of veterinary internal medicine. pp. 1211-1219. [Online]. 
  
Back to record